Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,654,170
+$4,275,393 QoQ
Shares Held
1,597,749
+10.6% QoQ
Ownership
0.876%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,654,170 | 1,597,749 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $8,378,777 | 1,444,617 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,886,605 | 1,386,829 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $11,095,869 | 1,363,129 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,040,784 | 1,293,530 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $6,594,587 | 1,201,200 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,055,731 | 1,196,381 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,300,944 | 1,158,226 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,491,129 | 1,107,169 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,562,616 | 1,159,555 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,738,602 | 1,165,363 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,130,103 | 1,145,217 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,022,911 | 1,153,783 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,808,610 | 1,109,577 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,458,174 | 1,096,372 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,707,611 | 1,094,623 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,701,597 | 1,104,934 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $528,506 | 206,448 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $556,763 | 190,022 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||